CytoDyn receives positive response from FDA for Phase 3 leronlimab study in COVID-19
December 21 2021 - 9:28AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Mar 2024 to Apr 2024
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2023 to Apr 2024